Philip P. Boudreau - 08 Aug 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EVP AND CFO
Signature
/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
08 Aug 2025
Transactions value $
-$746,758
Form type
4
Filing time
11 Aug 2025, 17:53:04 UTC
Previous filing
04 Mar 2025
Next filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boudreau Philip P EVP AND CFO 100 ABBOTT PARK ROAD, ABBOTT PARK /s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact 11 Aug 2025 0001805099

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Sale -$747K -5.55K -9.81% $134.55 51K 08 Aug 2025 Direct F1
holding ABT Common shares without par value 361 08 Aug 2025 Profit Sharing Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.551 to $134.58, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Balance in the Abbott Laboratories Stock Retirement Trust as of August 8, 2025.